{"transactions":[{"id":4076351,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":169755,"kind":"person","name":"Watler Peter K.","position":1,"cik":"0001622139","reported_name":"Watler Peter K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T16:07:46.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-18-002891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622139/000089924318002891/doc4.xml","form_type":"4"}},{"id":4126451,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":169755,"kind":"person","name":"Watler Peter K.","position":1,"cik":"0001622139","reported_name":"Watler Peter K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-12-19T16:05:56.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5900,"source":{"system":"sec-edgar","filing":"0000899243-17-029151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622139/000089924317029151/doc4.xml","form_type":"4"}},{"id":4240153,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":169755,"kind":"person","name":"Watler Peter K.","position":1,"cik":"0001622139","reported_name":"Watler Peter K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-08T16:05:54.000Z","date":"2017-08-06","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the \"Vesting Commencement Date\"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":67000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0000899243-17-019842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622139/000089924317019842/doc4.xml","form_type":"4"}}]}